Member Info for zebbo

I have posted a question re Orphan's genomic health data and how licensing is going. Also are license contracts RNS'd

If the market wobbles and it could well do. The US looks vulnerable. We could see £2 as things stand today.
Only giving my view...

Although not a pure covid play. I expect covid stocks to bounce back hard leading into Autumn. ORPH will also be in focus as a defensive play with massive growth potential. A real gem with massive upside potential

Totally agree covid stocks are going to bounce back hard. All of a sudden there will be a rush to get back in. I expect most to hit new highs as Autumn approaches.

All very subjective, depends of you are in the Bull or Bear camp

Thats why it can be best to switch off. Come back in 3 months and see where we are. Although I dont take my own advice..:-). I would be confident in this AIM stock to do that and 100% confident in CF as a business person to do whats required to deliver value
Now you cannot say that about many of the CEOs on AIM

https://total-market-solutions.com/2020/06/22/open-orphan-hvivo-2/
Some may not have seen this.....great info

Anything that could / should / would impact the value ie share price of the company should be reported via RNS.
So a non strategic order for 1000 tests may be deemed as non SP impacting and hence not notifiable
However a 1000 sample order from a top 5 pharma, whom is new to ODX may be deemed notifiable due to strategic importance / linkage
Obviously an order worth £1m, either to a strategic partner or not may be deemed as financially impacting to the company, hence an RNS would be issued.
Hope that helps

Each order placed should impact the SP. Obviously it will be the size / type of order that will impact the SP. Nice to see forward orders and selling of capacity.
SP may be choppy for the next week or so, then start rising against orders or anticipated orders
However I am expecting BIG support / demand from our very own government, based on our current C19 involvement

This should go way beyond 2p. On good drill results I would expect ~4p

We have NOT had an update that has been RNS'd showing commercial progress. We have had an update that adds nothing that is share price impacting

Better be, or we could well bomb out. The update was due at the end of June.
Next Mon is 7th July, so expect am update good or bad

they did and then bumped all these Bio stock on to the open market, in order to maximise return

Great move for the US fund, to screw these UK companies and their investors.

That aside, the shares will be shifted and we will move up smartly. No point providing rich news flow until they have sold up or nearly sold. Otherwise to are playing into there hands

Buy / sell spread is 0.03p, seller being worked through. Expect it to pop once clear

Best Bio / Pharma on AIM, bar none

News is nailed on for next week, twitter is AVCT hot.....

alwayswiinning - sounds like a desperate ODX ramp....lol

People desperately looking for a negatives.... eeek we are a day late.... the AVCT world is ending etc etc. Utter BS posted on this thread by neurotic kids
RELAX and take a few weeks away

Expect 2-3 months drill + analysis + results

Jimbo, no gun to your head. Sell up and move on if you feel that strongly

Did not expect much this week due to July 4th hols, lots of Americans take the week of. AS we do at Easter etc